RIVASTIGMINE-DRLA rivastigmine (as hydrogen tartrate) 1.5 mg capsule blister pack

Negara: Australia

Bahasa: Inggris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

rivastigmine hydrogen tartrate, Quantity: 2.4 mg (Equivalent: rivastigmine, Qty 1.5 mg)

Tersedia dari:

Dr Reddys Laboratories Australia Pty Ltd

INN (Nama Internasional):

rivastigmine hydrogen tartrate

Bentuk farmasi:

Capsule, hard

Komposisi:

Excipient Ingredients: sunset yellow FCF; titanium dioxide; microcrystalline cellulose; iron oxide yellow; sodium lauryl sulfate; Gelatin; hypromellose; magnesium stearate; colloidal anhydrous silica; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; Shellac; allura red AC; povidone; sodium hydroxide

Rute administrasi :

Oral

Unit dalam paket:

112, 28, 14, 56

Jenis Resep:

(S4) Prescription Only Medicine

Indikasi Terapi:

RIVASTIGMINE is indicated for the treatment of patients with mild to moderately severe dementia of the Alzheimer's type.

Ringkasan produk:

Visual Identification: White to off-white powder filled in size 2 hard gelatin capsules, yellow opaque colour cap, yellow opaque colour body, imprinted with 'RV' over '1.5' on body with red ink; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Status otorisasi:

Registered

Tanggal Otorisasi:

2012-09-24